Article Details

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20

Retrieved on: 2025-02-05 15:34:37

Tags for this article:

Click the tags to see associated articles and topics

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20. View article details on hiswai:

Excerpt

Expanding to Canada represents a significant step in our mission to evaluate Decoy20, a broad immune system activator, in patients with solid tumors.”.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo